The FDA’s database entry for application number ANDA089465 indicates that the injectable product Wellcovorin has been marked as discontinued.
Wellcovorin is an injectable formulation (route: injection) containing Leucovorin Calcium equivalent to 50 mg base per vial. The product is listed under product number 001 and is not a reference drug or reference standard.
The sponsor for this application is GlaxoSmithKline. The marketing status is recorded as discontinued, meaning the product is no longer marketed in the United States.
規制動向2026年9月16日•3分で読めます
FDA Discontinues Wellcovorin Injection (ANDA089465)
The FDA records show that the injectable product Wellcovorin, containing Leucovorin Calcium (50 mg per vial), has been marked as discontinued under ANDA089465.
Pharmacountryチームがまとめました · 出典： FDA.gov
トピック：
評価
(0)
(0)
(0)
(0)
(0)
評価を残す